Sabra Healthcare REIT Overview
Sabra Healthcare REIT (SBRA) has a ROE of 2.34%, below the Finance sector average of 17.11%.
Get informed when a big investor buys or sells
+ Follow2.34%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Sabra Healthcare REIT posts a ROE of 2.34%. That is below the Finance sector average of 17.11%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
For Finance stocks, a ROE near 17.11% is typical. Sabra Healthcare REIT's 2.34% is lower that level. That is roughly 86.3% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
Sabra Healthcare REIT's ROE moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 2.34%; use YoY and peer views to separate noise from signal.
Context for SBRA's ROE usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 17.11%), and (3) consistency with growth and profitability. This page covers the first two; Sabra Healthcare REIT's other metric pages and overview cover the third.
Judging Sabra Healthcare REIT against Finance peers is usually better than using a market-wide rule of thumb. Business models inside Finance are more comparable, which makes gaps in ROE easier to interpret. Start with 2.34% here, then scan peer and history charts to see if the gap is persistent.
